<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Juvenile Open Angle Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjWla8vRJ2d@c3ELTefQAAAAU","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Juvenile_Open_Angle_Glaucoma","wgTitle":"Juvenile Open Angle Glaucoma","wgCurRevisionId":89037,"wgRevisionId":89037,"wgArticleId":6535,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma","Pediatric Ophthalmology/Strabismus"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Juvenile_Open_Angle_Glaucoma","wgRelevantArticleId":6535,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit"
:[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},
"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Juvenile open-angle glaucoma (JOAG) is a rare subset of glaucoma diagnosed in individuals greater than 3 years old and less than 40 years of age. It is characterized by autosomal dominant inheritance and early age of onset. Compared to adult onset primary open-angle glaucoma (POAG), the juvenile form tends to be rapidly progressive with more severely elevated and fluctuating intraocular pressures (IOPs). In addition, JOAG is less responsive to medications and often requires surgical therapy. Surgical treatment most commonly consists of trabeculectomy although IOP control can be achieved with glaucoma drainage implants and angle surgery as well."/>
<meta name="date" content="2018-06-04"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Juvenile Open Angle Glaucoma" href="/w/index.php?title=Special:ExportRDF/Juvenile_Open_Angle_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Juvenile_Open_Angle_Glaucoma rootpage-Juvenile_Open_Angle_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Juvenile+Open+Angle+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Juvenile+Open+Angle+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzywt6uk"></button>
					<div class="collapse navbar-collapse hbpzywt6uk" id="hbpzywt6uk">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Juvenile_Open_Angle_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Juvenile_Open_Angle_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Juvenile_Open_Angle_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Juvenile Open Angle Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Shu.Feng" title="User:Shu.Feng">Shu Feng, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Hunter.Temple" title="User:Hunter.Temple">Hunter Temple</a>,&#160;<a href="/User:Joanne.C.Wen" title="User:Joanne.C.Wen">Joanne C.Wen, MD</a>,&#160;<a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>,&#160;<a href="/w/index.php?title=User:Christine_Y._Wong&amp;action=formedit&amp;redlink=1" class="new" title="User:Christine Y. Wong (page does not exist)">Christine Y. Wong</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Shu.Feng" title="User:Shu.Feng">Shu Feng, MD</a>,&#160;<a href="/User:Grace.Prakalapakorn" title="User:Grace.Prakalapakorn">S. Grace Prakalapakorn, MD, MPH</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>,&#32;<a href="/User:Allison.Umfress" title="User:Allison.Umfress">Allison Umfress, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table> </div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<p>Juvenile open-angle glaucoma (JOAG) is a rare subset of glaucoma diagnosed in individuals greater than 3 years old and less than 40 years of age. It is characterized by autosomal dominant inheritance and early age of onset. Compared to adult onset primary open-angle glaucoma (POAG), the juvenile form tends to be rapidly progressive with more severely elevated and fluctuating intraocular pressures (IOPs). In addition, JOAG is less responsive to medications and often requires surgical therapy. Surgical treatment most commonly consists of trabeculectomy although IOP control can be achieved with glaucoma drainage implants and angle surgery as well.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Disease_Entity"><span class="tocnumber">1</span> <span class="toctext">Disease Entity</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Disease"><span class="tocnumber">1.1</span> <span class="toctext">Disease</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Etiology"><span class="tocnumber">1.2</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Genetics"><span class="tocnumber">1.3</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Risk_Factors"><span class="tocnumber">1.4</span> <span class="toctext">Risk Factors</span></a>
<ul>
<li class="toclevel-3 tocsection-6"><a href="#Risk_factors_for_visual_field_.28VF.29_progression:"><span class="tocnumber">1.4.1</span> <span class="toctext">Risk factors for visual field (VF) progression:</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-7"><a href="#General_Pathology"><span class="tocnumber">1.5</span> <span class="toctext">General Pathology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#History"><span class="tocnumber">2.1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Physical_examination"><span class="tocnumber">2.2</span> <span class="toctext">Physical examination</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Diagnostic_procedures"><span class="tocnumber">2.3</span> <span class="toctext">Diagnostic procedures</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Laboratory_test"><span class="tocnumber">2.4</span> <span class="toctext">Laboratory test</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Differential_diagnosis"><span class="tocnumber">2.5</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-14"><a href="#Management"><span class="tocnumber">3</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-15"><a href="#General_treatment"><span class="tocnumber">3.1</span> <span class="toctext">General treatment</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Medical_therapy"><span class="tocnumber">3.2</span> <span class="toctext">Medical therapy</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Surgery"><span class="tocnumber">3.3</span> <span class="toctext">Surgery</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Disease_Entity">Disease Entity</span></h1>
<p>Juvenile open-angle glaucoma (JOAG)
</p>
<h2><span class="mw-headline" id="Disease">Disease</span></h2>
<p>Juvenile open-angle glaucoma (JOAG) is an uncommon subset of primary open-angle glaucoma (POAG) characterized by autosomal dominant inheritance and early age of onset. Like other forms of glaucoma, JOAG is a condition of optic nerve degeneration manifested by optic nerve head changes and corresponding visual field defects. JOAG is most commonly diagnosed in individuals between 5 and 35 years old and rarely after 40, but age at diagnosis is variable due to the insidious disease course.<sup id="cite_ref-turalba1_1-0" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup>
<sup id="cite_ref-wiggs2_2-0" class="reference"><a href="#cite_note-wiggs2-2">&#91;2&#93;</a></sup> In a study of 70 JOAG patients, the mean age at diagnosis was 26 ± 9.8 years.<sup id="cite_ref-gupta3_3-0" class="reference"><a href="#cite_note-gupta3-3">&#91;3&#93;</a></sup> JOAG should be distinguished from infantile glaucoma, which develops before the age of 3 and is a clinically distinct disease entity.<sup id="cite_ref-babiuch4_4-0" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup> The estimated prevalence of JOAG ranges from 0.38 to 2 in 100,000 in individuals between 4 and 20 years of age.<sup id="cite_ref-turalba1_1-1" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup><sup id="cite_ref-aponte5_5-0" class="reference"><a href="#cite_note-aponte5-5">&#91;5&#93;</a></sup> A study from the Dallas Glaucoma Registry estimates that JOAG comprises 4% of childhood glaucomas.<sup id="cite_ref-fung6_6-0" class="reference"><a href="#cite_note-fung6-6">&#91;6&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Etiology">Etiology</span></h2>
<p>As with primary open angle glaucoma, JOAG is associated with elevations in IOP. It is hypothesized that the increased IOP is due to an abnormal trabecular meshwork causing reduced aqueous outflow.<sup id="cite_ref-turalba1_1-2" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup> Evidence for this mechanism includes ultra-structural findings of thick compact tissue and extracellular deposits in the trabecular meshwork of individuals with JOAG.<sup id="cite_ref-furuyoshi7_7-0" class="reference"><a href="#cite_note-furuyoshi7-7">&#91;7&#93;</a></sup>
</p><p>It is possible that vascular perfusion of the optic nerve plays a role as well. A 2020 study used optical coherence tomography angiography (OCT-A) to investigate a correlation between vascular perfusion, RNFL thickness, and best corrected visual acuity (BCVA). They found that RNFL thickness had a strong correlation with peripapillary vessel density and BCVA also had a strong positive correlation with vessel density regardless of RNFL thickness.<sup id="cite_ref-abdelrahman1_8-0" class="reference"><a href="#cite_note-abdelrahman1-8">&#91;8&#93;</a></sup>Vessel densities were much lower in JOAG when compared with POAG.<sup id="cite_ref-ciociola2_9-0" class="reference"><a href="#cite_note-ciociola2-9">&#91;9&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Genetics">Genetics</span></h2>
<p>JOAG is inherited in an autosomal dominant pattern with high penetrance.<sup id="cite_ref-wiggs2_2-1" class="reference"><a href="#cite_note-wiggs2-2">&#91;2&#93;</a></sup> Of particular importance in the pathogenesis of JOAG is a gene called myocilin (MYOC). Genetic linkage analysis in pedigrees with JOAG identified a locus on chromosome 1q21-31 called GLC1A that was further refined to 1q23-25.<sup id="cite_ref-sheffield8_10-0" class="reference"><a href="#cite_note-sheffield8-10">&#91;10&#93;</a></sup><sup id="cite_ref-sunden9_11-0" class="reference"><a href="#cite_note-sunden9-11">&#91;11&#93;</a></sup> From this GLC1A locus, the TIGR (trabecular meshwork inducible glucocorticoid response) gene, later renamed myocilin, was isolated.<sup id="cite_ref-turalba1_1-3" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup> Mutations in myocilin are strongly linked with JOAG, occurring in up to 36% of affected individuals. Disease-causing myocilin mutations are also present in adult onset POAG but at a lesser prevalence of 4%.<sup id="cite_ref-shimizu10_12-0" class="reference"><a href="#cite_note-shimizu10-12">&#91;12&#93;</a></sup> The lifetime risk of developing glaucoma in MYOC mutation carriers is 60-100%.<sup id="cite_ref-gupta11_13-0" class="reference"><a href="#cite_note-gupta11-13">&#91;13&#93;</a></sup> In addition, patients with strong family histories of glaucoma have an increased likelihood of harboring a disease-causing myocilin mutation.<sup id="cite_ref-fingert12_14-0" class="reference"><a href="#cite_note-fingert12-14">&#91;14&#93;</a></sup> 
</p><p>Myocilin is so named because of its homology to myosin and localization to the ciliary rootlet.<sup id="cite_ref-turalba1_1-4" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup> Disease-causing mutations in myocilin are thought to increase aqueous outflow resistance as the protein product is expressed on the trabecular meshwork (including trabecular beams and juxtacanalicular connective tissue).<sup id="cite_ref-polansky13_15-0" class="reference"><a href="#cite_note-polansky13-15">&#91;15&#93;</a></sup><sup id="cite_ref-quigley14_16-0" class="reference"><a href="#cite_note-quigley14-16">&#91;16&#93;</a></sup> Myocilin mutations also may have prognostic value as phenotype has been found to correlate with severity of disease.<sup id="cite_ref-alward15_17-0" class="reference"><a href="#cite_note-alward15-17">&#91;17&#93;</a></sup>
<sup id="cite_ref-fingert16_18-0" class="reference"><a href="#cite_note-fingert16-18">&#91;18&#93;</a></sup> For example, the Gln368Stop mutation is associated with a mild phenotype with later age at diagnosis and lower mean IOP compared to the Tyr437His and Ile477Asn mutations.<sup id="cite_ref-turalba1_1-5" class="reference"><a href="#cite_note-turalba1-1">&#91;1&#93;</a></sup> Another important genetic variation is CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1), which may be a modifier gene that predisposes to JOAG.<sup id="cite_ref-furuyoshi7_7-1" class="reference"><a href="#cite_note-furuyoshi7-7">&#91;7&#93;</a></sup> CYP1B1 has also been linked to congenital glaucoma.<sup id="cite_ref-babiuch4_4-1" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup> 
</p><p>C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 (CPAMD8) is a protein in corneal endothelial cells and the non-pigmented ciliary epithelium that is involved in the pressure dynamics of the anterior chamber.<sup id="cite_ref-janssen1_19-0" class="reference"><a href="#cite_note-janssen1-19">&#91;19&#93;</a></sup><sup id="cite_ref-chen2_20-0" class="reference"><a href="#cite_note-chen2-20">&#91;20&#93;</a></sup> CPAMD8 is implicated in an autosomal recessive anterior segment dysgenesis and has been shown to play a role in some cases of JOAG; in some cohorts, it was the second most common mutation behind MYOC, suggesting that genetic testing for CPAMD8 should be considered for JOAG diagnosis and prognosis.<sup id="cite_ref-siggs3_21-0" class="reference"><a href="#cite_note-siggs3-21">&#91;21&#93;</a></sup> <sup id="cite_ref-balikov4_22-0" class="reference"><a href="#cite_note-balikov4-22">&#91;22&#93;</a></sup> Another study conducted in Australia and New Zealand looked at 327 individuals (622 eyes) with JOAG and found that MYOC was found in 9.5%, CYP1B1 in 3.2%, and CPAMD8, FOXC1, TBK1, COL2Z1, and OPTN were found in less than 1% of patients. Of these participants with JOAG, only around 15% received a molecular diagnosis.<sup id="cite_ref-knight5_23-0" class="reference"><a href="#cite_note-knight5-23">&#91;23&#93;</a></sup> <sup id="cite_ref-ciociola2_9-1" class="reference"><a href="#cite_note-ciociola2-9">&#91;9&#93;</a></sup> Further genetic studies must be completed to identify the genes associated with JOAG and genetic testing panels may be needed in the future for patient-tailored treatment plans.<sup id="cite_ref-ciociola2_9-2" class="reference"><a href="#cite_note-ciociola2-9">&#91;9&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Risk_Factors">Risk Factors</span></h2>
<ol><li>Male gender: In a study of 125 eyes, there was a male preponderance of 64%.<sup id="cite_ref-kwun17_24-0" class="reference"><a href="#cite_note-kwun17-24">&#91;24&#93;</a></sup></li>
<li>Myopia: 87% of JOAG individuals are myopic. In families with JOAG, myopia occurs more frequently in affected individuals.<sup id="cite_ref-wiggs18_25-0" class="reference"><a href="#cite_note-wiggs18-25">&#91;25&#93;</a></sup></li>
<li>Severe elevation of IOP: A characteristic feature of JOAG, IOPs generally range over 40 mmHg and even over 50mmHg.<sup id="cite_ref-alward15_17-1" class="reference"><a href="#cite_note-alward15-17">&#91;17&#93;</a></sup><sup id="cite_ref-fingert16_18-1" class="reference"><a href="#cite_note-fingert16-18">&#91;18&#93;</a></sup></li>
<li>African ancestry: There is a higher prevalence of JOAG in this population but not a corresponding higher frequency of MYOC mutations.<sup id="cite_ref-gupta11_13-1" class="reference"><a href="#cite_note-gupta11-13">&#91;13&#93;</a></sup></li>
<li>Prominent iris processes: This feature may be unrelated to JOAG as it is noted in both affected and unaffected family members in families with JOAG.<sup id="cite_ref-wiggs18_25-1" class="reference"><a href="#cite_note-wiggs18-25">&#91;25&#93;</a></sup></li>
<li>MYOC mutation: see Genetics.</li></ol>
<h3><span id="Risk_factors_for_visual_field_(VF)_progression:"></span><span class="mw-headline" id="Risk_factors_for_visual_field_.28VF.29_progression:">Risk factors for visual field (VF) progression:</span></h3>
<p>The projected lifetime risk of perimetric blindness in JOAG is similar to POAG despite the longer duration of disease in JOAG patients.<sup id="cite_ref-gupta19_26-0" class="reference"><a href="#cite_note-gupta19-26">&#91;26&#93;</a></sup>
</p>
<ol><li>Long-term IOP fluctuation is associated with faster rates of VF progression.<sup id="cite_ref-gupta20_27-0" class="reference"><a href="#cite_note-gupta20-27">&#91;27&#93;</a></sup></li>
<li>Higher IOP at the last visit<sup id="cite_ref-kwun17_24-1" class="reference"><a href="#cite_note-kwun17-24">&#91;24&#93;</a></sup></li>
<li>Family history of glaucoma is weakly associated with VF progression despite similar baseline and last IOPs, number of surgeries, medications, and baseline VF defect.<sup id="cite_ref-kwun17_24-2" class="reference"><a href="#cite_note-kwun17-24">&#91;24&#93;</a></sup></li></ol>
<h2><span class="mw-headline" id="General_Pathology">General Pathology</span></h2>
<p>Ultrastructural findings on electron microscopy showed similar findings to steroid-induced glaucoma, including abnormal extracellular material in a fingerprint-like pattern, resembling basement membrane-like material. A study of 11 trabeculectomy specimens found this material present in the outer corneoscleral and inner cribiform regions of the trabecular meshwork, which thickened the cribiform region to a greater degree compared to eyes with late onset POAG. There is also a significant amount of sheath-derived plaque material in the endothelial layer adjacent to Schlemm’s canal, which is a feature also seen in late onset POAG.<sup id="cite_ref-furuyoshi7_7-2" class="reference"><a href="#cite_note-furuyoshi7-7">&#91;7&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Diagnosis">Diagnosis</span></h1>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>As in POAG a significant proportion of individuals with JOAG are diagnosed when asymptomatic. If symptoms are present, these may include blurred vision, ocular pain from IOP elevation, or decreased visual acuity at later stages.<sup id="cite_ref-kwun17_24-3" class="reference"><a href="#cite_note-kwun17-24">&#91;24&#93;</a></sup> Patients should be asked about family history of glaucoma as well as other history that may indicate a secondary glaucoma. 
</p>
<h2><span class="mw-headline" id="Physical_examination">Physical examination</span></h2>
<p>Physical examination and findings of JOAG are similar to POAG. Exam should include measurement of IOP and central corneal thickness as well as assessment of the anterior chamber angle, optic disc, and visual fields.
</p>
<ol><li>IOP: Goldmann Applanation Tonometry (gold standard) or handheld devices such as the Tono-pen may be used. Young individuals may have a larger difference in measurement of IOP between these two methods.<sup id="cite_ref-bradfield21_28-0" class="reference"><a href="#cite_note-bradfield21-28">&#91;28&#93;</a></sup> See Intraocular Pressure and Tonometry.</li>
<li>Pachymetry: The role of pachymetry in evaluation or management of JOAG has not been formally studied but is currently recommended as part of the work-up for and pre-operative evaluation of JOAG.<sup id="cite_ref-babiuch4_4-2" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup><sup id="cite_ref-stangos22_29-0" class="reference"><a href="#cite_note-stangos22-29">&#91;29&#93;</a></sup></li>
<li>Anterior chamber angle: In JOAG the anterior segment generally appears normal on gonioscopy. However, with severely elevated pressures, dysgenesis of the angle may be present.<sup id="cite_ref-gupta23_30-0" class="reference"><a href="#cite_note-gupta23-30">&#91;30&#93;</a></sup> High iris insertion or prominent iris processes may also be seen.</li>
<li>Optic disc: Dilated eye exam often reveals bilateral cupping of the optic nerve head at the time of diagnosis.<sup id="cite_ref-babiuch4_4-3" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup> A recent analysis of optic discs using scanning laser ophthalmoscopy concluded that optic discs of JOAG tended to be larger in size compared to adult onset POAG discs including parameters of cup depth, volume, and cup to disc area ratio.<sup id="cite_ref-gupta24_31-0" class="reference"><a href="#cite_note-gupta24-31">&#91;31&#93;</a></sup> This is also true of treated JOAG discs compared to treated primary congenital glaucoma discs. There are no major structural or morphologic differences of the optic nerve head in myocilin mutations versus nonmyocilin glaucoma.<sup id="cite_ref-hewitt25_32-0" class="reference"><a href="#cite_note-hewitt25-32">&#91;32&#93;</a></sup></li>
<li>Visual field: Humphrey visual field (HVF) analysis via automated static threshold perimetry is the gold standard. For younger children for whom HVF is not possible, Goldmann visual fields may be used.<sup id="cite_ref-babiuch4_4-4" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup></li></ol>
<h2><span class="mw-headline" id="Diagnostic_procedures">Diagnostic procedures</span></h2>
<p>While not necessary for diagnosis, optical coherence tomography (OCT) is helpful for objectively monitoring disease progression in children, especially with the normal increase in axial length that accompanies growth.<sup id="cite_ref-ghasia26_33-0" class="reference"><a href="#cite_note-ghasia26-33">&#91;33&#93;</a></sup> Humphrey or Goldmann visual field tests may be used to detect early peripheral loss and to monitor progression.
</p>
<h2><span class="mw-headline" id="Laboratory_test">Laboratory test</span></h2>
<p>No laboratory testing is recommended for diagnosis of JOAG.
</p>
<h2><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span></h2>
<p>The differential for JOAG includes other types of open angle glaucoma, late congenital glaucoma, and secondary glaucomas including steroid-induced, traumatic, and inflammatory glaucoma.
</p><p>The differential for pediatric glaucoma also includes neovascularization of the iris (associated with retinoblastoma presenting with glaucoma), neovascular glaucoma, phakomatoses, juvenile xanthogranuloma, and medulloepithelioma.
</p><p>JOAG can be distinguished from late congenital glaucoma by the absence of the classic triad of symptoms: buphthalmos, tearing, and photophobia.<sup id="cite_ref-babiuch4_4-5" class="reference"><a href="#cite_note-babiuch4-4">&#91;4&#93;</a></sup> Exam findings of megalocornea, Descemet’s breaks (Haab’s striae), and anterior segment digenesis seen in congenital glaucoma are also absent in JOAG.<sup id="cite_ref-wiggs18_25-2" class="reference"><a href="#cite_note-wiggs18-25">&#91;25&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<h2><span class="mw-headline" id="General_treatment">General treatment</span></h2>
<p>Goals of treatment in JOAG include lowering IOP to prevent further degeneration of the optic nerve with serial imaging of the optic nerve head and perimetry to assess disease progression. IOP in JOAG tends to be refractory to maximally tolerated medical therapy and often requires surgical therapy for IOP control.<sup id="cite_ref-johnson27_34-0" class="reference"><a href="#cite_note-johnson27-34">&#91;34&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Medical_therapy">Medical therapy</span></h2>
<p>In contrast to congenital glaucoma, JOAG is first treated medically followed by adjunctive surgery. It should be noted, however, that medical therapy is often used as a bridge to surgery due to persistently elevated IOPs. In a study of multiple pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31, glaucoma filtration surgery was required in 83% of these patients.<sup id="cite_ref-wiggs18_25-3" class="reference"><a href="#cite_note-wiggs18-25">&#91;25&#93;</a></sup> 
</p><p>Medical therapy is similar to mangagement of POAG and includes carbonic anhydrase inhibitors, prostaglandin analogues (including latanoprost, which is ineffective in congenital glaucoma), beta blockers, and adrenergic agonists. Miotics such as pilocarpine are poorly tolerated due to ciliary spasm and induced myopia. In addition, alpha-agonists should be used with caution in small children due to adverse side effects such as central nervous system depression; for this reason, apraclonidine may be preferable to brimonidine in young children with JOAG.<sup id="cite_ref-talbot28_35-0" class="reference"><a href="#cite_note-talbot28-35">&#91;35&#93;</a></sup>
</p><p>Selective laser trabeculoplasty (SLT) has resulted in successful IOP reduction in certain patients. In one prospective study published in 2018, 30 JOAG eyes underwent SLT and 43% had significant IOP reduction (&gt;20% reduction) at 12 months without further medication or surgery. They also found that patients without angle dysgenesis were four times more likely to succeed.<sup id="cite_ref-gupta1_36-0" class="reference"><a href="#cite_note-gupta1-36">&#91;36&#93;</a></sup> A follow up study published in 2022 investigated SLT outcomes on patients without angle dysgenesis, which they defined as an absence of Schlemm’s canal and/or presence of a hyperreflective membrane over the trabecular meshwork (TM), as identified on anterior segment optical coherence tomography (ASOCT) before the SLT procedure. Their results show that SLT was 8.3 times more likely to be successful when Schlemm’s canal was visualized on 2 consecutive ASOCT and 21.4 times more likely to be successful when it was visualized on &gt;50% of ASOCTs. Meanwhile, SLT failed to reduce IOP in any eyes with a hyperreflective membrane over the TM.<sup id="cite_ref-varshney2_37-0" class="reference"><a href="#cite_note-varshney2-37">&#91;37&#93;</a></sup> These studies show that SLT can be a reasonable treatment option in JOAG and is much more likely to result in a successful IOP reduction when Schlemm’s canal is visualized on ASOCT and there is not a hyperreflective membrane. 
</p>
<h2><span class="mw-headline" id="Surgery">Surgery</span></h2>
<p>Options for surgical therapy of JOAG include filtration procedures (trabeculectomy), drainage implants, angle procedures (goniotomy, trabeculotomy), and cycloablative procedures.<sup id="cite_ref-ikeda29_38-0" class="reference"><a href="#cite_note-ikeda29-38">&#91;38&#93;</a></sup> 
</p><p>Trabeculectomy has been the mainstay of surgical therapy for JOAG. Three years postoperatively, IOP control without medications has been reported to occur at rates of 50-87%.<sup id="cite_ref-gupta30_39-0" class="reference"><a href="#cite_note-gupta30-39">&#91;39&#93;</a></sup><sup id="cite_ref-pathania31_40-0" class="reference"><a href="#cite_note-pathania31-40">&#91;40&#93;</a></sup><sup id="cite_ref-tsai32_41-0" class="reference"><a href="#cite_note-tsai32-41">&#91;41&#93;</a></sup> However, filtering surgery in JOAG is generally less successful compared to adult POAG because of a more robust healing response in young eyes. Intraoperative antifibrotics such as mitomycin C (MMC) have been used in an attempt to prevent fibrosis.<sup id="cite_ref-tsai32_41-1" class="reference"><a href="#cite_note-tsai32-41">&#91;41&#93;</a></sup> Although addition of MMC compared to trabeculectomy alone has resulted in lower IOPs, there is an increased risk of adverse effects including hypotony maculopathy and bleb-related infection. This led the authors of a retrospective analysis of 44 eyes to caution against using MMC with an initial trabeculectomy for JOAG.<sup id="cite_ref-tsai32_41-2" class="reference"><a href="#cite_note-tsai32-41">&#91;41&#93;</a></sup>
</p><p>Glaucoma drainage implants (GDIs) such as the Ahmed glaucoma valve, Molteno implant, and Baerveldt implant are an alternative surgical therapy for JOAG. A GDI may be preferable when significant conjunctival scarring precludes filtration surgery.<sup id="cite_ref-ishida33_42-0" class="reference"><a href="#cite_note-ishida33-42">&#91;42&#93;</a></sup> In a retrospective study of the Ahmed glaucoma valve used for pediatric glaucoma, there was a 100% success rate at 1 year defined as a final IOP between 6-18 mmHg without loss of light perception or reoperation for glaucoma.<sup id="cite_ref-balekudaru34_43-0" class="reference"><a href="#cite_note-balekudaru34-43">&#91;43&#93;</a></sup> In a study of 52 eyes with juvenile glaucoma, the Molteno implant resulted in IOP control &lt; 21 with a probability of 0.89 at 1 year.<sup id="cite_ref-ahchan35_44-0" class="reference"><a href="#cite_note-ahchan35-44">&#91;44&#93;</a></sup> 
</p><p>Micro invasive glaucoma surgery (MIGS) procedures have also been tried for JOAG with some documented success. There have been two documented cases of Xen gel stent (Allergan, Irvine, CA) placement in 2 patients (4 eyes; one 35-year-old pregnant woman and one 48-year-old woman) with 100% success rate of IOP reduction, with elimination of eye drop burden at 2 months and 16 months follow up, respectively.<sup id="cite_ref-klug1_45-0" class="reference"><a href="#cite_note-klug1-45">&#91;45&#93;</a></sup> <sup id="cite_ref-zehavidorin2_46-0" class="reference"><a href="#cite_note-zehavidorin2-46">&#91;46&#93;</a></sup> These two cases suggest the possible efficacy of Xen gel stent in JOAG.  Another case report published in 2022 discusses the use of a Hydrus stent (Alcon, Forth Worth, TX)  in combination with cataract surgery. In this case report of a single patient with JOAG (one eye) with preoperative pressures of 25 mmHg, surgery resulted in decreased IOP that was stable at 14 mmHg at 21 months post operatively.<sup id="cite_ref-oseni3_47-0" class="reference"><a href="#cite_note-oseni3-47">&#91;47&#93;</a></sup> Based on these few reports, MIGS implants may be a viable option for pressure control, but further study on both their safety and efficacy in larger cohorts is needed. 
</p><p>Angle procedures are more commonly used in surgical management of congenital glaucoma and less often for JOAG. However, there are reports of successful angle surgery in JOAG.<sup id="cite_ref-stangos22_29-1" class="reference"><a href="#cite_note-stangos22-29">&#91;29&#93;</a></sup> For example, 360-degree trabeculotomy facilitated by illuminated microcatheter has also been used. In a study of 10 eyes using this technique, there was a 50% reduction in mean IOP. Another retrospective study compared outcomes after gonioscopy-assisted transluminal trabeculotomy (GATT) (n=36) to goniotomy with the Kahook Dual Blade (KDB, New World Medical, Rancho Cucamonga, CA) (n=13) in JOAG eyes. The study found GATT resulted in significant mean IOP reductions of approximately 44% to a mean IOP of 15.4 mmHg, and a mean medication reduction of 2.6 at three months post-operatively.  KDB was less successful with a mean IOP reduction of 14% to a mean IOP of 20 mmHg, and a mean medication reduction of 0.7 at three months. Of these patients only 5/36 GATT eyes required a second glaucoma procedure compared to 8/13 KDB eyes. In the GATT group at six months follow up, 90% eliminated at least one drug and 11 GATT patients were drug free.  <sup id="cite_ref-qiao_48-0" class="reference"><a href="#cite_note-qiao-48">&#91;48&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-turalba1-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-turalba1_1-0">1.0</a></sup> <sup><a href="#cite_ref-turalba1_1-1">1.1</a></sup> <sup><a href="#cite_ref-turalba1_1-2">1.2</a></sup> <sup><a href="#cite_ref-turalba1_1-3">1.3</a></sup> <sup><a href="#cite_ref-turalba1_1-4">1.4</a></sup> <sup><a href="#cite_ref-turalba1_1-5">1.5</a></sup></span> <span class="reference-text">Turalba AV, Chen TC. Clinical and genetic characteristics of primary juvenile-onset open-angle glaucoma (JOAG). Semin Ophthalmol. 2008;23(1):19-25.</span>
</li>
<li id="cite_note-wiggs2-2"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-wiggs2_2-0">2.0</a></sup> <sup><a href="#cite_ref-wiggs2_2-1">2.1</a></sup></span> <span class="reference-text">Wiggs JL, Damji KF, Haines JL, Pericak-Vance MA, Allingham RR. The distinction between juvenile and adult-onset primary open-angle glaucoma. Am J Hum Genet. 1996;58(1):243-244.</span>
</li>
<li id="cite_note-gupta3-3"><span class="mw-cite-backlink"><a href="#cite_ref-gupta3_3-0">↑</a></span> <span class="reference-text">Gupta V, Dutta P, OV M, Kapoor KS, Sihota R, Kumar G. Effect of glaucoma on the quality of life of young patients. Invest Ophthalmol Vis Sci. 2011;52(11):8433-8437.</span>
</li>
<li id="cite_note-babiuch4-4"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-babiuch4_4-0">4.0</a></sup> <sup><a href="#cite_ref-babiuch4_4-1">4.1</a></sup> <sup><a href="#cite_ref-babiuch4_4-2">4.2</a></sup> <sup><a href="#cite_ref-babiuch4_4-3">4.3</a></sup> <sup><a href="#cite_ref-babiuch4_4-4">4.4</a></sup> <sup><a href="#cite_ref-babiuch4_4-5">4.5</a></sup></span> <span class="reference-text">Babiuch AE, Bradfield YS. Diagnosis and Management of Juvenile Open-Angle Glaucoma. In: Traboulsi, E. UV, eds. Practical Management of Pediatric Ocular Disorders and Strabismus. New York, NY     Springer; 2016:471-477.</span>
</li>
<li id="cite_note-aponte5-5"><span class="mw-cite-backlink"><a href="#cite_ref-aponte5_5-0">↑</a></span> <span class="reference-text">Aponte EP, Diehl N, Mohney BG. Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol. 2010;128(4):478-482.</span>
</li>
<li id="cite_note-fung6-6"><span class="mw-cite-backlink"><a href="#cite_ref-fung6_6-0">↑</a></span> <span class="reference-text">Fung DS, Roensch MA, Kooner KS, Cavanagh HD, Whitson JT. Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry. Clin Ophthalmol. 2013;7:1739-1746.</span>
</li>
<li id="cite_note-furuyoshi7-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-furuyoshi7_7-0">7.0</a></sup> <sup><a href="#cite_ref-furuyoshi7_7-1">7.1</a></sup> <sup><a href="#cite_ref-furuyoshi7_7-2">7.2</a></sup></span> <span class="reference-text">Furuyoshi N, Furuyoshi M, Futa R, Gottanka J, Lütjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of juvenile glaucoma. Ophthalmologica. 1997;211(3):140-146.</span>
</li>
<li id="cite_note-abdelrahman1-8"><span class="mw-cite-backlink"><a href="#cite_ref-abdelrahman1_8-0">↑</a></span> <span class="reference-text">Abdelrahman AM, Eltanamly RM, Elsanabary Z, Hassan LM. Optical coherence tomography angiography in juvenile open angle glaucoma: correlation between structure and perfusion. Int Ophthalmol 2020; 41:883–889.</span>
</li>
<li id="cite_note-ciociola2-9"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-ciociola2_9-0">9.0</a></sup> <sup><a href="#cite_ref-ciociola2_9-1">9.1</a></sup> <sup><a href="#cite_ref-ciociola2_9-2">9.2</a></sup></span> <span class="reference-text">Ciociola EC, Klifto MR. Juvenile open angle glaucoma: current diagnosis and management. Curr Opin Ophthalmol. 2022;33(2):97-102. doi:10.1097/ICU.0000000000000813</span>
</li>
<li id="cite_note-sheffield8-10"><span class="mw-cite-backlink"><a href="#cite_ref-sheffield8_10-0">↑</a></span> <span class="reference-text">Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet. 1993;4(1):47-50.</span>
</li>
<li id="cite_note-sunden9-11"><span class="mw-cite-backlink"><a href="#cite_ref-sunden9_11-0">↑</a></span> <span class="reference-text">Sunden SL, Alward WL, Nichols BE, et al. Fine mapping of the autosomal dominant juvenile open angle glaucoma (GLC1A) region and evaluation of candidate genes. Genome Res. 1996;6(9):862-869.</span>
</li>
<li id="cite_note-shimizu10-12"><span class="mw-cite-backlink"><a href="#cite_ref-shimizu10_12-0">↑</a></span> <span class="reference-text">Shimizu S, Lichter PR, Johnson AT, et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol. 2000;130(2):165-177.</span>
</li>
<li id="cite_note-gupta11-13"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-gupta11_13-0">13.0</a></sup> <sup><a href="#cite_ref-gupta11_13-1">13.1</a></sup></span> <span class="reference-text">Gupta V, Somarajan BI, Gupta S, et al. The inheritance of juvenile onset primary open angle glaucoma. Clin Genet. 2017;92(2):134-142.</span>
</li>
<li id="cite_note-fingert12-14"><span class="mw-cite-backlink"><a href="#cite_ref-fingert12_14-0">↑</a></span> <span class="reference-text">Fingert JH. Primary open-angle glaucoma genes. Eye (Lond). 2011;25(5):587-595.</span>
</li>
<li id="cite_note-polansky13-15"><span class="mw-cite-backlink"><a href="#cite_ref-polansky13_15-0">↑</a></span> <span class="reference-text">Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 1997;211(3):126-139.</span>
</li>
<li id="cite_note-quigley14-16"><span class="mw-cite-backlink"><a href="#cite_ref-quigley14_16-0">↑</a></span> <span class="reference-text">Quigley HA. The search for glaucoma genes--implications for pathogenesis and disease detection. N Engl J Med. 1998;338(15):1063-1064.</span>
</li>
<li id="cite_note-alward15-17"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-alward15_17-0">17.0</a></sup> <sup><a href="#cite_ref-alward15_17-1">17.1</a></sup></span> <span class="reference-text">Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338(15):1022-1027.</span>
</li>
<li id="cite_note-fingert16-18"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-fingert16_18-0">18.0</a></sup> <sup><a href="#cite_ref-fingert16_18-1">18.1</a></sup></span> <span class="reference-text">Fingert JH, Stone EM, Sheffield VC, Alward WL. Myocilin glaucoma. Surv Ophthalmol. 2002;47(6):547-561.</span>
</li>
<li id="cite_note-janssen1-19"><span class="mw-cite-backlink"><a href="#cite_ref-janssen1_19-0">↑</a></span> <span class="reference-text">Janssen SF, Gorgels TG, Ten Brink JB, Jansonius NM, Bergen AA. Gene expression-based comparison of the human secretory neuroepithelia of the brain choroid plexus and the ocular ciliary body: potential implications for glaucoma. Fluids Barriers CNS. 2014;11(1):2. Published 2014 Jan 29. doi:10.1186/2045-8118-11-2</span>
</li>
<li id="cite_note-chen2-20"><span class="mw-cite-backlink"><a href="#cite_ref-chen2_20-0">↑</a></span> <span class="reference-text">Chen Y, Huang K, Nakatsu MN, Xue Z, Deng SX, Fan G. Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells. Hum Mol Genet. 2013;22(7):1271-1279. doi:10.1093/hmg/dds527</span>
</li>
<li id="cite_note-siggs3-21"><span class="mw-cite-backlink"><a href="#cite_ref-siggs3_21-0">↑</a></span> <span class="reference-text">Siggs OM, Souzeau E, Taranath DA, et al. Biallelic CPAMD8 Variants Are a Frequent Cause of Childhood and Juvenile Open-Angle Glaucoma. Ophthalmology. 2020;127(6):758-766. doi:10.1016/j.ophtha.2019.12.024 </span>
</li>
<li id="cite_note-balikov4-22"><span class="mw-cite-backlink"><a href="#cite_ref-balikov4_22-0">↑</a></span> <span class="reference-text">Balikov DA, Jacobson A, Prasov L. Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders. Genes (Basel). 2021;12(9):1403. Published 2021 Sep 11. doi:10.3390/genes12091403 </span>
</li>
<li id="cite_note-knight5-23"><span class="mw-cite-backlink"><a href="#cite_ref-knight5_23-0">↑</a></span> <span class="reference-text">Knight LSW, Ruddle JB, Taranath DA, et al. Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry. Ophthalmology. 2021;128(11):1549-1560. doi:10.1016/j.ophtha.2021.04.016</span>
</li>
<li id="cite_note-kwun17-24"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-kwun17_24-0">24.0</a></sup> <sup><a href="#cite_ref-kwun17_24-1">24.1</a></sup> <sup><a href="#cite_ref-kwun17_24-2">24.2</a></sup> <sup><a href="#cite_ref-kwun17_24-3">24.3</a></sup></span> <span class="reference-text">Kwun Y, Lee EJ, Han JC, Kee C. Clinical Characteristics of Juvenile-onset Open Angle Glaucoma. Korean J Ophthalmol. 2016;30(2):127-133.</span>
</li>
<li id="cite_note-wiggs18-25"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-wiggs18_25-0">25.0</a></sup> <sup><a href="#cite_ref-wiggs18_25-1">25.1</a></sup> <sup><a href="#cite_ref-wiggs18_25-2">25.2</a></sup> <sup><a href="#cite_ref-wiggs18_25-3">25.3</a></sup></span> <span class="reference-text">Wiggs JL, Del Bono EA, Schuman JS, Hutchinson BT, Walton DS. Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31. Ophthalmology. 1995;102(12):1782-1789.</span>
</li>
<li id="cite_note-gupta19-26"><span class="mw-cite-backlink"><a href="#cite_ref-gupta19_26-0">↑</a></span> <span class="reference-text">Gupta V, Markan A, Somarajan BI, et al. Phenotypic differences between familial versus non-familial Juvenile onset open angle glaucoma patients. Ophthalmic Genet. 2018;39(1):63-67.</span>
</li>
<li id="cite_note-gupta20-27"><span class="mw-cite-backlink"><a href="#cite_ref-gupta20_27-0">↑</a></span> <span class="reference-text">Gupta V, Devi K S, Kumar S, et al. Risk of perimetric blindness among juvenile glaucoma patients. Ophthalmic Physiol Opt. 2015;35(2):206-211.</span>
</li>
<li id="cite_note-bradfield21-28"><span class="mw-cite-backlink"><a href="#cite_ref-bradfield21_28-0">↑</a></span> <span class="reference-text">Bradfield YS, Kaminski BM, Repka MX, et al. Comparison of Tono-Pen and Goldmann applanation tonometers for measurement of intraocular pressure in healthy children. J AAPOS. 2012;16(3):242-248.</span>
</li>
<li id="cite_note-stangos22-29"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-stangos22_29-0">29.0</a></sup> <sup><a href="#cite_ref-stangos22_29-1">29.1</a></sup></span> <span class="reference-text">Stangos AN, Whatham AR, Sunaric-Megevand G. Primary viscocanalostomy for juvenile open-angle glaucoma. Am J Ophthalmol. 2005;140(3):490-496.</span>
</li>
<li id="cite_note-gupta23-30"><span class="mw-cite-backlink"><a href="#cite_ref-gupta23_30-0">↑</a></span> <span class="reference-text">Gupta V, Srivastava RM, Rao A, Mittal M, Fingert J. Clinical correlates to the goniodysgensis among juvenile-onset primary open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2013;251(6):1571-1576.</span>
</li>
<li id="cite_note-gupta24-31"><span class="mw-cite-backlink"><a href="#cite_ref-gupta24_31-0">↑</a></span> <span class="reference-text">Gupta V, James MK, Singh A, et al. Differences in Optic Disc Characteristics of Primary Congenital Glaucoma, Juvenile, and Adult Onset Open Angle Glaucoma Patients. J Glaucoma. 2016;25(3):239-243.</span>
</li>
<li id="cite_note-hewitt25-32"><span class="mw-cite-backlink"><a href="#cite_ref-hewitt25_32-0">↑</a></span> <span class="reference-text">Hewitt AW, Bennett SL, Fingert JH, et al. The optic nerve head in myocilin glaucoma. Invest Ophthalmol Vis Sci. 2007;48(1):238-243.</span>
</li>
<li id="cite_note-ghasia26-33"><span class="mw-cite-backlink"><a href="#cite_ref-ghasia26_33-0">↑</a></span> <span class="reference-text">Ghasia FF, El-Dairi M, Freedman SF, Rajani A, Asrani S. Reproducibility of spectral-domain optical coherence tomography measurements in adult and pediatric glaucoma. J Glaucoma. 2015;24(1):55-63.</span>
</li>
<li id="cite_note-johnson27-34"><span class="mw-cite-backlink"><a href="#cite_ref-johnson27_34-0">↑</a></span> <span class="reference-text">Johnson AT, Drack AV, Kwitek AE, Cannon RL, Stone EM, Alward WL. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology. 1993;100(4):524-529.</span>
</li>
<li id="cite_note-talbot28-35"><span class="mw-cite-backlink"><a href="#cite_ref-talbot28_35-0">↑</a></span> <span class="reference-text">Talbot AW, Russell-Eggitt I. Pharmaceutical management of the childhood glaucomas. Expert Opin Pharmacother. 2000;1(4):697-711.</span>
</li>
<li id="cite_note-gupta1-36"><span class="mw-cite-backlink"><a href="#cite_ref-gupta1_36-0">↑</a></span> <span class="reference-text">Gupta V, Ghosh S, Sujeeth M, et al. Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years. Can J Ophthalmol. 2018;53(1):81-85. doi:10.1016/j.jcjo.2017.07.023</span>
</li>
<li id="cite_note-varshney2-37"><span class="mw-cite-backlink"><a href="#cite_ref-varshney2_37-0">↑</a></span> <span class="reference-text">Varshney T, Azmira K, Gupta S, et al. In Vivo Imaging of the Schlemm's Canal and the Response to Selective Laser Trabeculoplasty. Am J Ophthalmol. 2022;234:126-137. doi:10.1016/j.ajo.2021.07.002</span>
</li>
<li id="cite_note-ikeda29-38"><span class="mw-cite-backlink"><a href="#cite_ref-ikeda29_38-0">↑</a></span> <span class="reference-text">Ikeda H, Ishigooka H, Muto T, Tanihara H, Nagata M. Long-term outcome of trabeculotomy for the treatment of developmental glaucoma. Arch Ophthalmol. 2004;122(8):1122-1128.</span>
</li>
<li id="cite_note-gupta30-39"><span class="mw-cite-backlink"><a href="#cite_ref-gupta30_39-0">↑</a></span> <span class="reference-text">Gupta V, Ghosh S, Sujeeth M, et al. Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years. Can J Ophthalmol. 2018;53(1):81-85.</span>
</li>
<li id="cite_note-pathania31-40"><span class="mw-cite-backlink"><a href="#cite_ref-pathania31_40-0">↑</a></span> <span class="reference-text">Pathania D, Senthil S, Rao HL, Mandal AK, Garudadari CS. Outcomes of trabeculectomy in juvenile open angle glaucoma. Indian J Ophthalmol. 2014;62(2):224-228.</span>
</li>
<li id="cite_note-tsai32-41"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-tsai32_41-0">41.0</a></sup> <sup><a href="#cite_ref-tsai32_41-1">41.1</a></sup> <sup><a href="#cite_ref-tsai32_41-2">41.2</a></sup></span> <span class="reference-text">Tsai JC, Chang HW, Kao CN, Lai IC, Teng MC. Trabeculectomy with mitomycin C versus trabeculectomy alone for juvenile primary open-angle glaucoma. Ophthalmologica. 2003;217(1):24-30.</span>
</li>
<li id="cite_note-ishida33-42"><span class="mw-cite-backlink"><a href="#cite_ref-ishida33_42-0">↑</a></span> <span class="reference-text">Ishida K, Mandal AK, Netland PA. Glaucoma drainage implants in pediatric patients. Ophthalmol Clin North Am. 2005;18(3):431-442, vii.</span>
</li>
<li id="cite_note-balekudaru34-43"><span class="mw-cite-backlink"><a href="#cite_ref-balekudaru34_43-0">↑</a></span> <span class="reference-text">Balekudaru S, Vadalkar J, George R, Vijaya L. The use of Ahmed glaucoma valve in the management of pediatric glaucoma. J AAPOS. 2014;18(4):351-356.</span>
</li>
<li id="cite_note-ahchan35-44"><span class="mw-cite-backlink"><a href="#cite_ref-ahchan35_44-0">↑</a></span> <span class="reference-text">Ah-Chan JJ, Molteno AC, Bevin TH, Herbison P. Otago Glaucoma Surgery Outcome Study: follow-up of young patients who underwent Molteno implant surgery. Ophthalmology. 2005;112(12):2137-2142.</span>
</li>
<li id="cite_note-klug1-45"><span class="mw-cite-backlink"><a href="#cite_ref-klug1_45-0">↑</a></span> <span class="reference-text">Klug E, Solá-Del Valle D. Bilateral XEN Gel Stent Implantation in Juvenile-Onset Open-Angle Glaucoma. Case Rep Ophthalmol. 2020;11(2):336-341. Published 2020 Jul 14. doi:10.1159/000508391 </span>
</li>
<li id="cite_note-zehavidorin2-46"><span class="mw-cite-backlink"><a href="#cite_ref-zehavidorin2_46-0">↑</a></span> <span class="reference-text">Zehavi-Dorin T, Heinecke E, Nadkarni S, Green C, Chen C, Kong YXG. Bilateral consecutive Xen gel stent surgery during pregnancy for uncontrolled early-onset primary open angle glaucoma. Am J Ophthalmol Case Rep. 2019;15:100510. Published 2019 Jul 11. doi:10.1016/j.ajoc.2019.100510</span>
</li>
<li id="cite_note-oseni3-47"><span class="mw-cite-backlink"><a href="#cite_ref-oseni3_47-0">↑</a></span> <span class="reference-text">Oseni J, Laroche D. Cataract surgery and Hydrus stent implantation in juvenile open-angle glaucoma: A case report [published online ahead of print, 2022 Sep 24]. J Natl Med Assoc. 2022;S0027-9684(22)00155-9. Doi:10.1016/j.jnma.2022.09.004</span>
</li>
<li id="cite_note-qiao-48"><span class="mw-cite-backlink"><a href="#cite_ref-qiao_48-0">↑</a></span> <span class="reference-text">Qiao Y, Tan C, Chen X, Sun X, Chen J. Gonioscopy-assisted transluminal trabeculotomy versus goniotomy with Kahook dual blade in patients with uncontrolled juvenile open-angle glaucoma: a retrospective study. BMC Ophthalmol. 2021;21(1):395. Published 2021 Nov 16. doi:10.1186/s12886-021-02159-z</span>
</li>
</ol></div>
<ol><li value="49">Lim ME, Dao JB, Freedman SF. 360-Degree Trabeculotomy for Medically Refractory Glaucoma Following Cataract Surgery and Juvenile Open-Angle Glaucoma. Am J Ophthalmol. 2017;175:1-7.</li>
<li>Leung CK, Woo J, Tsang MK, Tse KK. Structural and functional recovery in juvenile open angle glaucoma after trabeculectomy. Eye (Lond). 2006;20(1):132-134.</li>
<li>Ely AL, El-Dairi MA, Freedman SF. Cupping reversal in pediatric glaucoma--evaluation of the retinal nerve fiber layer and visual field. Am J Ophthalmol. 2014;158(5):905-915.</li>
</ol>
<!-- 
NewPP limit report
Cached time: 20230306035156
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.003 seconds
CPU time usage: 0.271 seconds
Real time usage: 2.073 seconds
Preprocessor visited node count: 1163/1000000
Post‐expand include size: 6618/2097152 bytes
Template argument size: 1826/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 25599/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  643.874      1 Template:Article
100.00%  643.874      1 -total
 89.06%  573.418      4 Template:Infobox_section
 57.20%  368.322     11 Template:UserLookup
  5.61%   36.138      1 Template:Review_expired
  2.13%   13.683      1 Template:Infobox_begin
  0.21%    1.362      1 Template:Get_active_contest
  0.15%    0.971      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;oldid=89037">https://eyewiki.org/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;oldid=89037</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li><li><a href="/Category:Pediatric_Ophthalmology/Strabismus" title="Category:Pediatric Ophthalmology/Strabismus">Pediatric Ophthalmology/Strabismus</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzywtlpi">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Juvenile_Open_Angle_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Juvenile_Open_Angle_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;oldid=89037" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Juvenile_Open_Angle_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on January 26, 2023, at 08:52.</div>
					<div>This page has been accessed 46,591 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAFgAAAAfCAMAAABUFvrSAAACJVBMVEXe3t62trbLy8vGxsbAwMDX19e6urqsrKxHcEzQ0NC2tratra2oqKixsbHd3eDFxcXe3t7U1NTa2trX19fQ0NDV1dWNjY2dnZ2UlJSUlJTS0tKUlJSWlpbR0dGenp79/f38/Pz+/v7t7e3v7+/u7u7s7Oz19fX29vb6+vr7+/vz8/Pz8/P4+fnw8PD39/gWTq/09PX6+vktX7b/sg8XT7F6mc/f5OwhVrNvkMthhsfT2+j7rQ/M1eZqjcmFotPs7e9Cb722xuFResK/zOObstnu7/Grvd3M1+mNqNY6aLoaUbEaUbZWfsTk6fE2Zrnp7O8bTq0kWLQuYcpcg8Xh5/Byk83a4eukud1/nM+6yeQkWcGwwuDxnRQyYrigttvI0+gpW7XGyttLdsBni8geVLo0Z9XlkCPb4u+QqtcfVLLo7PNHcr73phFGX6HsmBnpkxg6bNwnXcbX3er19vnr7/SVrdhuhLl+j70vVqY6Xqv0oxJVcbQhV76DjKTz9ffQ2evE0OZAbbzu7/PS1uFufrDnrGgpSZjy8/SQnMFddrKuekXSiCsgTKRaaZHejy9yang3VptNaqspWbnmliy3j2/m6OzT3e7x8fL4+v3p6uwaN2re0cifqLiLiZWYhYGYb0xXYn+5g0xwiMKYpc2BcHZmW2srRXpGWIhecKfilz4+WID2+PyosMywqbGqss1aVnLZq33p1sGklZqrp7dkfr7CpY9yg59Ud6QZAAAAH3RSTlPfBN/f39/f2wDf39vV3/7N2rrEz5D5c8ONuHaPuXXDImoxqwAABO1JREFUSMe1kQdz01gQgBXaBS4w9OtHwMFSdPKTUNxkW+61xN2Je4tLHJNOGukkAUINJTzaUIbO9fr7TpLtS44DZiC5b6Sn3dW+TysJaWz4cv9eZFPZu/+bhkakYR88WqP59u3vjxzdDCT7GpCD4qNH3sEGzOhB5MCR/4PmA8j25uZ33t0A23lxff5hZTIzOrz2Ph8qK936l7i1tT7hk8DAoHNsbeLWKjPdQcZ+qvX9tHMNXca1XBDXHtL6x2Bh0HWtuXUo8oTgC1gVpcdsdpew92PUYtjwzFq+E9mJYfXxx1x5l2/l5Vhy0DW6TuyQCZcR2hnswXJM0h+203471u5WKMIE5mDpspIIO8sZTMZiIbczY6+JCaI+/sJZ38qjP28+nQjkx/mcqGJ26rW3iKg/fYphCL1jNk5WbqXI0nBnu00RJ2j9bNRp6MmFS0SYIXLuUlQ5w22qizHr5MTyy2u/3XxVvHHlwtWVa/xTCQIIlEaMzrgswzA5P9BrAciYASqNoiNdjL8b0GYAHN3AGAEgzPSQc9UtYCeyBQAMO2G9PhhzXfp9qdifSCT6Lj788QQnrvWEuNPI2um0LW0D+m4A6E4AnIZOeq7ksQuJvi6eUXRW+8EWXsxNPhkYGJiSXr7Rd1qtVp9MXHkgIurzAkdFxjrj7cmKbN4K5v8RGxT2sJMTpwBflNHhUJgBdoUylzy3TuwIDBRi0hf9p9VtbW3qk30X7q2Je1IybZq7mLVWFKTSADXPoqi9AzVorda0kKTS6KkRbSgaR1GT1h5CObYiW1GU27yc5z6F9Fn/yTYedeLi9AIA6AbgxGIxAMPZcZeUHH9cFavVfY97FaNA/DbazRZVV89/61at2BTlg1JXiFtrYoBmRyd7p6/UP0XxaSDmy4pt0jmuh8qx6wQ2MmRz18TaJCUWO9xisUVhMMsoZZDiGHLLuXUbso2iatP/1HvhYu3n3bh6Pe/LUjZSj1NUJ8lSlNwahRRlMRjmyFDICikVn8+SacomdbZTVj+0mQSxweS1WqpiHK/Ncubs858f9idOJ/qKS1cv+RbFuIbMmHEvTbO4QeF25CxyD62nSbmJ1MUzRrpiwR0RPBJMpnCGxWVGXBn8TkarNGQHjuPrxOeWY4GY9FmxWHy19Gvv+ayYF6f8oYi7i8U93bjFkYokvbhWEFu8Og2ZxrUe3NMpc3vLhqqYpVV4XbwDQkpgoVwYKOR9N5d+eXB5vJevQA0pD7oVqi4WOj16vX6EYSA08WKvyeOZJw1cQ6rsnXOa/RYoM0Kls0zLuVoHhHAHL8YFXkwVCoE8uXhvMVCY8mW5Ci8eKkcgJ9azOl0UajNDFiUpj5JeloEqTgwd/iCUJP0sFMSejkpO96b4zl1fPuYiyd6Vs4GBmHSsJoYmLy/WeBTlis5rlJYrgjhe1s+XOXGEtHJOMl4VB2EHLauKdyG7JBLIc//uslRKkhOrcGJqyiU9z5UkOpVOwiGXSyQizRAfqlRc7Y5KJFnV6FReiWSV7xAWeQd/SOSq6qY18eVHq4vjlyazEJ73ScmJPVxJVKdF9MFwYpFIEL+ehvDOcSH8YXRsAa4XfwS7kd0tLfw7Sp7fl7xJywbYjTTVotfTb+849lEcb0K+2lMN/5o+tons+Rxp+PrQ8U3n0BcNSGPj4W+bPuX5ZLNo+uxwY+PfoLJHX1KXgyMAAAAASUVORK5CYII=" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.003},"limitreport":{"cputime":"0.271","walltime":"2.073","ppvisitednodes":{"value":1163,"limit":1000000},"postexpandincludesize":{"value":6618,"limit":2097152},"templateargumentsize":{"value":1826,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":25599,"limit":5000000},"timingprofile":["100.00%  643.874      1 Template:Article","100.00%  643.874      1 -total"," 89.06%  573.418      4 Template:Infobox_section"," 57.20%  368.322     11 Template:UserLookup","  5.61%   36.138      1 Template:Review_expired","  2.13%   13.683      1 Template:Infobox_begin","  0.21%    1.362      1 Template:Get_active_contest","  0.15%    0.971      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035156","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":2777});});</script></body>
</html>